文献速递头颈部肿瘤放疗

口咽癌IB区淋巴结受累风险:颌下腺保护性照射的指导

The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
PubMed 文献 · Pract Radiat Oncol · 2017-02-16

本研究回顾性分析92例接受初次手术及同侧IB区淋巴结清扫的口咽鳞癌患者,共102个颌下淋巴结清扫标本。影像学阴性者中,同侧IB区病理阳性率在口咽癌为4.3%、HPV阳性口咽癌为5.3%;IB区以外阳性淋巴结负荷高可能与IB区病理阳性相关。

要点

  • 早期口咽癌同侧IB区病理受累风险低(4.3%)。
  • HPV阳性口咽癌同侧IB区病理阳性率为5.3%。
  • IB区以外阳性淋巴结负荷高可能提示IB区受累风险增加。

核心结论

  • 早期口咽鳞癌同侧IB区病理受累风险低。
  • IB区邻近区域高阳性淋巴结负荷可能与IB区病理受累风险升高相关。

研究设计与样本

  • 回顾性队列研究,纳入2010至2016年92例接受初次手术及同侧IB区淋巴结清扫的口咽鳞癌患者,共分析102个颌下淋巴结清扫标本(92个同侧、10个对侧),排除影像学阳性病例。

主要发现

  • 影像学阴性者中,同侧IB区病理阳性率在口咽癌为4.3%,在HPV阳性口咽癌为5.3%。
  • IB区以外同侧颈部阳性淋巴结负荷与IB区病理阳性相关:IB区病理阴性患者中50%有2个及以上阳性淋巴结,而IB区病理阳性患者中75%有4个及以上阳性淋巴结。

临床怎么用

  • 对于早期口咽鳞癌、影像学IB区阴性且IB区以外阳性淋巴结负荷不高的患者,可考虑省略同侧IB区照射以保护颌下腺。

局限性

  • 回顾性 Chart Review 设计。
  • 样本量有限(92例患者、102个清扫标本)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Xerostomia remains a common side effect of head and neck irradiation. Conflicting data exist regarding the likelihood of level IB involvement for patients with oropharyngeal squamous cell cancer (OPSCC), and data are limited on this risk in patients with human papillomavirus-positive disease. This study examined surgically treated OPSCC to determine the risk of pathologic level IB nodal involvement and to identify a cohort of patients in whom ipsilateral level IB radiation therapy may be safely omitted. METHODS AND MATERIALS: A total of 102 submandibular nodal dissections were identified (92 ipsilateral and 10 contralateral) in 92 patients from 2010 to 2016 in those undergoing primary surgical treatment and dissection of ipsilateral level IB lymph nodes. Radiographically positive cases were excluded. Retrospective chart review was used for data collection, and the rate of pathologic level IB involvement was determined. RESULTS: The ipsilateral level IB nodal station had negative imaging and pathologically positive nodes at rates of 4.3% in OPSCC and 5.3% in human papillomavirus-positive OPSCC. Positive node burden in the ipsilateral neck at stations other than IB appeared to correlate with the risk of pathologic positive IB (pIB+) nodes: 50% of pathologically IB-negative patients had 2 or more positive nodes versus 75% of pIB+ patients who had 4 or more positive nodes. CONCLUSIONS: Our data indicate a low risk of pathologic level IB involvement in early-stage OPSCC. High positive node burden in stations near level IB may be associated with a higher chance of pathologic level IB involvement.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Lee NCJ, Kelly JR, Park HS, et al. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation. Pract Radiat Oncol. 2017. PMID: 28356201. doi:10.1016/j.prro.2017.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。